Protein farnesyltransferase: Structure and implications for substrate binding

被引:78
作者
Dunten, P [1 ]
Kammlott, U [1 ]
Crowther, R [1 ]
Weber, D [1 ]
Palermo, R [1 ]
Birktoft, J [1 ]
机构
[1] Hoffmann La Roche Inc, Roche Res Ctr, Nutley, NJ 07110 USA
关键词
D O I
10.1021/bi980531o
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The rat protein farnesyltransferase crystal structure has been solved by multiple isomorphous replacement methods at a resolution of 2.75 Angstrom. The three-dimensional structure, together with recent data on the effects of several mutations, led us to propose a model for substrate binding which differs from the model presented by Park et al, based on their independent structure determination [Park, H. W., Boduluri, S. R., Moomaw, J. F., Casey, P. J., and Beese, L. S. (1997) Science 275, 1800-1804]. Both farnesyl diphosphate and peptide substrates can be accommodated in the hydrophobic active-site barrel, with the sole charged residue inside the barrel, Arg202 of the beta-subunit, forming a salt bridge with the negatively charged carboxy terminus of peptide substrates. Our proposals are based in part on the observation of electron density in the active site which can be modeled as bound famesyl diphosphate carried through the enzyme purification. In addition, our model explains in structural terms the results of mutational studies which have identified several residues critical for substrate specificity and catalysis.
引用
收藏
页码:7907 / 7912
页数:6
相关论文
共 26 条
  • [1] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [2] Brunger A. T., 1992, X PLOR VERSION 3 1 S
  • [3] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods
    delaFortelle, E
    Bricogne, G
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 : 472 - 494
  • [4] DelVillar K, 1997, J BIOL CHEM, V272, P680
  • [5] Yeast protein farnesyltransferase. Site-directed mutagenesis of conserved residues in the beta-subunit
    Dolence, JM
    Rozema, DB
    Poulter, CD
    [J]. BIOCHEMISTRY, 1997, 36 (30) : 9246 - 9252
  • [6] PROTEIN FARNESYLTRANSFERASE - KINETICS OF FARNESYL PYROPHOSPHATE BINDING AND PRODUCT RELEASE
    FURFINE, ES
    LEBAN, JJ
    LANDAVAZO, A
    MOOMAW, JF
    CASEY, PJ
    [J]. BIOCHEMISTRY, 1995, 34 (20) : 6857 - 6862
  • [7] The potential of farnesyltransferase inhibitors as cancer chemotherapeutics
    Gibbs, JB
    Oliff, A
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 : 143 - 166
  • [8] Errors in protein structures
    Hooft, RWW
    Vriend, G
    Sander, C
    Abola, EE
    [J]. NATURE, 1996, 381 (6580) : 272 - 272
  • [9] Hutchinson EG, 1996, PROTEIN SCI, V5, P212
  • [10] BENZODIAZEPINE PEPTIDOMIMETICS - POTENT INHIBITORS OF RAS FARNESYLATION IN ANIMAL-CELLS
    JAMES, GL
    GOLDSTEIN, JL
    BROWN, MS
    RAWSON, TE
    SOMERS, TC
    MCDOWELL, RS
    CROWLEY, CW
    LUCAS, BK
    LEVINSON, AD
    MARSTERS, JC
    [J]. SCIENCE, 1993, 260 (5116) : 1937 - 1942